Investors in Exelixis Inc (Symbol: EXEL) saw new options become available this week, for the November 21st expiration. One of the key inputs that goes into the price an option buyer is willing to ...

The BNP and several left-leaning parties have expressed concerns over the spreadsheet format of the recommendations sent by ...

Exelixis' future depends on trial outcomes and patent risks. Find out why EXEL stock is a "Sell" despite cabozantinib's strong performance.

(NASDAQ:EXEL) stands against other best biotech stocks ... These equities have substantial upside potential and, should ...

Exelixis (NasdaqGS:EXEL) saw an 11% share price increase over the last quarter, a period marked by significant achievements ...

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Exelixis (EXEL) or argenex SE (ARGX). But which of these two stocks presents investors with ...

The equity portion of the Abrdn Healthcare Investors Fund fell (gross of fees) but outperformed its custom benchmark over the ...

Sorry you don't approve of my house! I can't hear you over the sound of having a place to live for $1,000/month.

No matter how many tools I try, I keep coming back to Excel for project management. Find out why Excel trumps other PM tools.